ヘパリン:抗凝固薬としての100年以上
1Therapeutic Reference Materials, Medicines and Healthcare Products Regulator Agency, South Mimms, UK. john.hogwood@mhra.gov.uk.
Handbook of experimental pharmacology
|December 30, 2025
まとめ
重要な抗凝固薬であるヘパリンは、血栓の治療と医療処置の実施において100年以上にわたり不可欠でした。低分子量ヘパリンのような進歩は、自己投与の利点を提供します。
科学分野:
- 生化学
- 薬理学
- 医学史
背景:
- ヘパリンは1世紀以上にわたり医学に不可欠でした。
- 血栓形成傾向の状態や透析のような処置の管理において重要な役割を果たしています。
- ヘパリンは、心臓手術のための体外循環の開発に役立ちました。
研究 の 目的:
- ヘパリンの包括的な概要を提供すること。
- その発見、構造、作用機序を詳述すること。
- 抗凝固におけるその主な使用を強調すること。
主な方法:
- ヘパリンに関する歴史的および科学的データの文献レビュー。
- 臨床実践および医学的進歩におけるヘパリンの役割の分析。
- 低分子量ヘパリンを含むヘパリン療法の進化の検討。
主要な成果:
- ヘパリンの発見と構造は、その抗凝固特性の基礎となります。
- その作用機序は、治療的応用において重要です。
- ヘパリンの使用は、予防、血栓塞栓性イベントの治療、透析、心臓手術に及びます。
結論:
- ヘパリンは、抗凝固療法の礎であり続けています。
- 低分子量ヘパリンの開発により、患者の利便性と自己投与が向上しました。
- この章では、ヘパリンの広範な歴史と有用性の簡潔な要約を提供します。
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
257
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
257
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
274
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
274
Venous Thrombosis IV: Nursing Management
176
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
176
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K


